- Home
- LINK vs IMA Comparison
LINK vs IMA Comparison
Compare LINK & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LINK | IMA |
|---|---|---|
| Founded | 1984 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.5M | 65.4M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | LINK | IMA |
|---|---|---|
| Price | $3.29 | $6.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | $8.67 | ★ $16.00 |
| AVG Volume (30 Days) | 28.2K | ★ 43.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,679,000.00 | N/A |
| Revenue This Year | $8.30 | N/A |
| Revenue Next Year | $34.68 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.76 | $5.70 |
| 52 Week High | $15.15 | $17.50 |
Technical Indicators
Market Signals| Indicator | LINK | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 44.20 | 45.20 |
| Support Level | $2.76 | $6.58 |
| Resistance Level | $4.11 | $7.17 |
| Average True Range (ATR) | 0.30 | 0.37 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 29.52 | 12.09 |
Price Performance
Historical ComparisonAbout LINK Interlink Electronics Inc.
Interlink Electronics Inc is a sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.